准备,质量评估和初步的药理动力学和药理动力学研究的 synephrine 干粉吸入器
Jiming Ke1,2,3, Shenao Li1, Miaomiao Zi1,3
1School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Drug delivery
|April 8, 2025
概括
赛内林干粉吸入器 (SYN-DPI) 通过减少炎症和氧化应激,有效治疗急性肺损伤 (ALI). 吸入剂可以提高synephrine的生物可用性和肺部输送,为ALI患者提供了有前途的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 急性肺损伤 (ALI) 是一种具有高死亡率的严重疾病,其特征是肺炎和膜-毛细血管屏障损伤.
- 目前对ALI的治疗方法有限,需要新的治疗策略.
- 赛内弗林是一种类衍生化合物,表现出抗炎和抗氧化特性.
研究的目的:
- 开发和评估用于治疗ALI的synephrine干粉吸入器 (SYN-DPI).
- 评估SYN-DPI的体外和体内疗效,安全性和药理动力学特征.
主要方法:
- 使用抗溶剂沉制备的synephrine干粉吸入器 (SYN-DPI).
- 在实验室中对SYN-DPI进行表征,包括湿度和空气动力学特性.
- 在体内和体外评估抗炎和抗氧化作用,毒性和药理动力学.
主要成果:
- SYN-DPI显示出低湿度和有利的空气动力学特性.
- 在体外和体内,SYN-DPI具有低毒性和显著的抗炎和抗氧化能力.
- 通过吸入注射synephrine导致生物可用性增加,肺损伤标志物减少.
结论:
- 赛内林干粉吸入器 (SYN-DPI) 是一种可行的配方,用于吸入赛内林的输送.
- SYN-DPI有效地减轻与ALI相关的炎症,氧化应激和肺损伤.
- 吸入的synephrine为改善急性肺损伤结果提供了一个有希望的治疗选择.
相关概念视频
01:28Adrenergic Agonists: Mixed-Action Agents
631
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
631
01:23Inhaled Medications
205
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
205
01:28Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
01:24Antiasthma Drugs: Methylxanthines
130
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
130
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K